alexa A Brazilian Experience with a Diabetes Program for Patient Safety in a Tertiary Hospital | OMICS International
ISSN: 2155-6156
Journal of Diabetes & Metabolism

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

A Brazilian Experience with a Diabetes Program for Patient Safety in a Tertiary Hospital

Gustavo Daher, Rodrigo Bomeny de Paulo, Rogerio Silicani Ribeiro and Jose Antonio Maluf de Carvalho*

Chronic Conditions and Elderly, Hospital Israelita Albert Einstein, Sao Paulo, Brazil

*Corresponding Author:
Dr. Jose Antonio Maluf de Carvalho
Chronic Conditions and Elderly, Hospital Israelita Albert Einstein
Sao Paulo, 05410-000, Brazil
Tel: 55/11/21511317; 55/11/994088483
E-mail: [email protected]

Received date: March 28, 2015; Accepted date: May 12, 2015; Published date: May 16, 2015

Citation: Daher G, de Paulo RB, Ribeiro RS, de Carvalho JAM (2015) A Brazilian Experience with a Diabetes Program for Patient Safety in a Tertiary Hospital. J Diabetes Metab 6:549. doi:10.4172/2155-6156.1000549

Copyright: © 2015 Daher G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Diabetes & Metabolism

Diabetes mellitus is a global health problem estimated to affect 400 million people; among those 50% do not have the correct diagnosis or treatment [1]. In Brazil, the national data is not precise, and diabetes should affect 6% to 12% of the population, representing almost 25 million people [2,3]. The prevalence of the disease increases with age and it is often accompanied by others majors chronic conditions such as hypertension, dyslipidemia and cardiovascular disease (stroke and myocardial infarction among others). The combination of these factors represents a significant impact on health costs. In 2014 the estimated diabetes costs worldwide were of U$612 billion, signifying more than 10% of general health expenditures [1].

Patients with type 1 or 2 diabetes mellitus are frequently hospitalized for treatment of conditions other than their diabetes. Therefore, the in-hospital prevalence of these disorders may be even more dramatic. General data estimates that 25-35% of the patients admitted have diabetes; out of which 4-10% did not had the diagnostic established prior to the hospitalization [4,5]. The Hospital Israelita Albert Einstein, located in São Paulo, Brazil, registered up to 4.000 patients with the diagnosis of diabetes on its discharge registries in 2013 [6]. Hyperglycemia related to acute stress conditions or others factors, such as medications in non-diabetic hospitalized patients is also very frequent, reaching a prevalence as high as 40-80% on critical care units [6-8].

Diabetes or hyperglycemia on hospitalized patients is related to higher rates of diabetes related complications, including hypoglycemia, a severe condition related to glycemic management, as well as, higher rates of infections and mortality. Those consequences reflect on longer periods of hospitalization and higher costs in comparison with nondiabetic and non-hyperglycemic patients. Therefore, an efficient inhospital prevention and treatment of diabetes and adequate glycemic control, provided by a specialized team, is an important security and quality issue, that may also impact limiting the cost of care [7-12].

Taking into account this scenario, since 2007 the Hospital Israelita Albert Einstein started a series of initiatives aiming a better assistance to diabetic or hyperglycemic patients. Initially, education courses for a multidisciplinary team where held providing knowledge on diabetes pathophysiology, management and education. This education process was the basis for developing an institutional program for Diabetes care that was inaugurated in 2009.

During the first 8 years since the beginning of the educational process the Diabetes Program has capacitated 147 multidisciplinary staff members that are responsible for the multiplication of the knowledge to the rest of the staff and to provide direct diabetes education to the patients. Those staff members are continuously educated in the Diabetes Program by regular classes and by electronic based training.

In 2009, protocols and institutional policies were implemented with specific blood glucose targets. Technical capacitation for all caring professionals for the correct utilization of these protocols were provided by the Diabetes Program and an electronic system of glucose monitoring was initiated providing reliable glucose data from all the admitted patients.

All adult patients (18 years old or more) admitted (including those admitted on the Emergencies department and on Diagnostic centers) are screened for hypoglycemic risk. Patients are questioned about the current medications in use, past history of hypoglycemia or diagnosis of diabetes. If positive screening occurs the patient is identified by a specific blue string that is a visual sign for hypoglycemia risk, and the patient and responsible are oriented about signs, symptoms and strategies to avoid hypoglycemia. Concomitantly, a multidisciplinary team starts planning an individual strategy (nutritional status, medication, controls) that could minimize the risk and the consequences of any hypoglycemia.

A specific protocol is available for a fast recognition of hypoglycemia by any member of the staff and to an immediate correction of the event. The correction, as described on the protocol, can be performed by any member of the nursing staff without a specific need of medical prescription, involving even the use of intravenous glucose.

All the glucose data is monitored on a daily basis by the nurses and physicians of the Diabetes Program. A designed team analyses all the hypoglycemic events (defined as blood glucose values less than 60 mg/ dL) that occur in the adult wards and critical care units. These analyses are made directly on the unit where it happens; the events are classified at the bedside as processes or therapeutic failures, enabling direct education of the involved staff with the event or eventually suggestions for changes of a specific therapy (medical, nutritional or others).

During the process of hypoglycemia vigilance and analysis since the implementation of the glucose monitoring in 2009, barriers for the adequate assistance of our patients were seen. One of the most important noticed issues were fasting and nutritional changes that were not correctly observed or expected. For that reason a complete engagement of nutritional team was essential, monitoring not only what is prescribed but also the real intake of carbohydrate of each patient that has potential risk of hypoglycemia and signalizing to the nurse staff the correct timing of the meal, essential information for the correct timing on glucose control and bolus insulin injection. Other major barriers found were use of drugs that could interfere with glycemic control (an alert system integrated with the hospital pharmacy is currently being implemented) and deficiencies of the care transition for patients from different hospital areas (a special team is being formed to improve the care transitions inside the hospital complex).

Since the implementation of the Diabetes Program a hypoglycemia index rate directly related with patient security was generated. This rate is part of the hospital security dashboard. This index is defined by the absolute number of hypoglycemic episodes divided by the absolute number of all the glycemic records performed on the adult units monitored by the Program. Since 2008 hypoglycemia rate has decreased in 80% (Figure 1), ensuring the improvement on the quality and safety assistance provided by the actions taken.

diabetes-metabolism-hypoglycemic-episodes

Figure 1: Hypoglycemia rate: number of hypoglycemic episodes (blood glucose <60mg/dL) divided by the number of all glycemic records.

Protocols for the management of hyperglycemia were also introduced during the same period. Patients on the critical care unit that have glycemic values above 180 mg/dL are eligible for an intravenous insulin algorithm, aiming a glucose target of 140-180 mg/ dL. This protocol is started by the unit’s medical staff, being afterwards directly conducted by the unit nurse staff using an electronic online calculator.

Ward hyperglycemic patients are also eligible for a subcutaneous insulin protocol, that begins with a basal-bolus insulin protocol defined by the patient weight and after that is adjusted by the Diabetes Program according to the glycemic control presented.

All patients under any insulin protocol are directly managed by the Diabetes Program nurses and physicians and hyperglycemia and normoglycemia index rates are also monitored on a daily basis and are part of the Diabetes Program indicator.

After the implementation and success presented by these actions on December 2013, the Hospital Israelita Albert Einstein was the first hospital outside the United States of America to have its Diabetes Program certified by the Joint Commission International. After the accreditation, actions are being taken to increase the protocol use and improve glycemic control, specially the hyperglycemia index. Specific programs and educational initiatives (ex. An online video platform) are being developed to provide direct patient education and empowerment and, by so, guaranteeing continuous excellence assistance to the diabetic and hyperglycemic patient admitted to our hospital.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • Annual Congress on Research and Innovations in Medicine July 02-03, 2018 Bangkok, Thailand
    July 02-03, 2018 Bangkok, Thailand
  • International Conference on Medical and Health Science August 24-25, 2018 Tokyo, JAPAN
    August 24-25, 2018 Tokyo, Japan

Article Usage

  • Total views: 11775
  • [From(publication date):
    June-2015 - Jun 20, 2018]
  • Breakdown by view type
  • HTML page views : 8023
  • PDF downloads : 3752
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7